Drug intelligence / Profile preview

Trexvia

Development stage: Unknown
Lead developer: Blue Heron Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

Trexvia is a multivitamin and dietary supplement product developed by Blue Heron Pharmaceuticals. It is marketed as a capsule formulation and is part of a portfolio of approximately 18 OTC and prescription nutritional products. As a multivitamin, it typically contains a combination of essential vitamins and minerals intended to support general health or address specific nutritional deficiencies. The product is listed with an NDC code, indicating its availability as a regulated nutritional product in the United States.

Brand names: Trexvia
Other names: Trexvia Multivitamin Capsules

Beyond the preview

Go deeper on Trexvia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trexvia.

Explore the full profile